2026年04月
JSCI-FOCIS Emerging Investigator Recognition Award 2026

2026年01月
The 19th YRAR Young Investigator Award

2025年09月
APLAR 2025 Travel Award on JCR

2025年04月
JCR 2025 ICW Excellent Abstract Award

2024年04月
JCR 2024 ICW Excellent Abstract Award

2023年04月
JCR 2023 ICW Excellent Abstract Award

Effectiveness and Safety of Sarilumab in Polymyalgia Rheumatica: a retrospective study of the FIRST Registry.
Naoaki Ohkubo; Yusuke Miyazaki; Satoshi Kubo; Ippei Miyagawa; Koshiro Sonomoto; Yoshino Inoue; Yurie Satoh-Kanda; Hiroaki Tanaka; Masanobu Ueno; Atsushi Nagayasu; Takafumi Aritomi; Ryuichiro Kanda; Yuya Fujita; Masashi Funada; Hidenori Sakai; Kiyotake Yoshioka; Mayu Nishimoto; Kazuki Takahashi; Shingo Nakayamada; Yoshiya Tanaka
Modern rheumatology, 2026年03月

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational study.
Takafumi Aritomi; Koshiro Sonomoto; Shingo Nakayamada; Hiroaki Tanaka; Atsushi Nagayasu; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Naoaki Ohkubo; Yasuyuki Todoroki; Yurie Satoh-Kanda; Masanobu Ueno; Ryuichiro Kanda; Yuya Fujita; Masashi Funada; Hidenori Sakai; Satsuki Matsunaga; Hiroaki Tanaka; Masayuki Shinojima; Hiroki Kawamura; Kazuki Takahashi; Miyabi Ando; Kazuki Haru; Yusuke Miyazaki; Kentaro Hanami; Masao Nawata; Shunsuke Fukuyo; Keisuke Nakatsuka; Mikiko Tokunaga; Kazuyoshi Saito; Yoshiya Tanaka
Arthritis & rheumatology (Hoboken, N.J.), 2026年03月

Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry
Hidenori Sakai; Koshiro Sonomoto; Shingo Nakayamada; Masanobu Ueno; Atsushi Nagayasu; Takafumi Aritomi; Hiroaki Tanaka; Satoshi Kubo; Ippei Miyagawa; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Ryuichiro Kanda; Yoshiya Tanaka
RMD Open, 2026年02月
筆頭著者

Pivotal contribution of super-enhancer-driven KLF6 expression to the adipogenesis of human adipose-derived stem cells.
Mai-Phuong Nguyen; Kaoru Yamagata; Anh Phuong Nguyen; Tong Zhang; Hidenori Sakai; Uyen Thi Ngo; Yu Shan; Takashi Otsuka; Ngo Thi Dieu Huong; Takafumi Aritomi; Meng Yuan; Shigeaki Kato; Yoshiya Tanaka; Shingo Nakayamada
Inflammation and regeneration, 2026年01月

Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry.
Masanobu Ueno; Koshiro Sonomoto; Hiroaki Tanaka; Atsushi Nagayasu; Takafumi Aritomi; Ippei Miyagawa; Satoshi Kubo; Yusuke Miyazaki; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Hidenori Sakai; Shingo Nakayamada; Yoshiya Tanaka
RMD open, 2026年01月

Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry
Koshiro Sonomoto; Shingo Nakayamada; Hidenori Sakai; Masanobu Ueno; Hiroaki Tanaka; Atsushi Nagayasu; Takafumi Aritomi; Makoto Okawara; Akinori Nakata; Yoshiya Tanaka
RMD Open, 2026年01月

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Atsushi Nagayasu; Yusuke Miyazaki; Koshiro Sonomoto; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Hiroaki Tanaka; Yasuyuki Todoroki; Masanobu Ueno; Takafumi Aritomi; Yuya Fujita; Hidenori Sakai; Katsunori Suzuki; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology and therapy, 2025年05月

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from FIRST registry.
Satoshi Kubo; Yusuke Miyazaki; Hiroaki Tanaka; Yuya Fujita; Hidenori Sakai; Masanobu Ueno; Yasuyuki Todoroki; Yurie Satoh-Kanda; Ippei Miyagawa; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology (Oxford, England), 2025年05月

Critical roles of IL-6 signaling in myoblast differentiation of human adipose-derived mesenchymal stem cells.
Takashi Otsuka; Kaoru Yamagata; Mai-Phuong Nguyen; Uyen Thi Ngo; Hidenori Sakai; Gulzhan Trimova; Junpei Anan; Yosuke Okada; Shingo Nakayamada; Yoshiya Tanaka
Inflammation and regeneration, 2025年04月

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Ryuichiro Kanda; Yusuke Miyazaki; Shingo Nakayamada; Shunsuke Fukuyo; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Yurie Satoh-Kanda; Naoaki Ohkubo; Yasuyuki Todoroki; Hiroaki Tanaka; Masanobu Ueno; Atsushi Nagayasu; Yuya Fujita; Takafumi Aritomi; Katsuhide Kusaka; Hidenori Sakai; Satsuki Matsunaga; Hirotsugu Nohara; Yoshiya Tanaka
Rheumatology and therapy, 2025年04月

Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry
Hidenori Sakai; Yusuke Miyazaki; Shingo Nakayamada; Satoshi Kubo; Kentaro Hanami; Shunsuke Fukuyo; Ayako Yamaguchi; Ippei Miyagawa; Masanobu Ueno; Hiroaki Tanaka; Yasuyuki Todoroki; Naoaki Ohkubo; Masashi Funada; Satsuki Matsunaga; Yoshiya Tanaka
Rheumatology, 2025年04月
筆頭著者

Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.
Naoaki Ohkubo; Yusuke Miyazaki; Shingo Nakayamada; Shunsuke Fukuyo; Yoshino Inoue; Yurie Satoh-Kanda; Hiroaki Tanaka; Yasuyuki Todoroki; Hiroko Miyata; Atsushi Nagayasu; Masashi Funada; Hiroki Kobayashi; Hidenori Sakai; Shumpei Kosaka; Satsuki Matsunaga; Yukiko Tomoyose; Hirotsugu Nohara; Yoshiya Tanaka
Rheumatology and therapy, 2024年10月

Cricoarytenoid arthritis in rheumatoid arthritis.
Shinji Izuka; Shunta Kaneko; Takuya Harada; Hidenori Sakai; Yuko Takahashi; Hiroyuki Yamashita; Hiroshi Kaneko
Rheumatology (Oxford, England), 2021年08月

Critical roles of IL-6 signaling in myoblast differentiation of human adipose-derived mesenchymal stem cells.
Otsuka Takashi, Yamagata Kaoru, Nguyen Mai-Phuong, Ngo Uyen Thi, Sakai Hidenori, Trimova Gulzhan, Anan Junpei, Okada Yosuke, Nakayamada Shingo, Tanaka Yoshiya
Inflammation and regeneration, 2025年04月, 査読あり, 招待無し

Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Sakai Hidenori, Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Hanami Kentaro, Fukuyo Shunsuke, Yamaguchi Ayako, Miyagawa Ippei, Ueno Masanobu, Tanaka Hiroaki, Todoroki Yasuyuki, Ohkubo Naoaki, Funada Masashi, Matsunaga Satsuki, Tanaka Yoshiya
Rheumatology (Oxford, England), 2024年09月, 査読あり, 招待無し
筆頭著者

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from FIRST registry.
Kubo Satoshi, Miyazaki Yusuke, Tanaka Hiroaki, Fujita Yuya, Sakai Hidenori, Ueno Masanobu, Todoroki Yasuyuki, Satoh-Kanda Yurie, Miyagawa Ippei, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology (Oxford, England), 2025年05月, 査読あり, 招待無し

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Kanda Ryuichiro, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Satoh-Kanda Yurie, Ohkubo Naoaki, Todoroki Yasuyuki, Tanaka Hiroaki, Ueno Masanobu, Nagayasu Atsushi, Fujita Yuya, Aritomi Takafumi, Kusaka Katsuhide, Sakai Hidenori, Matsunaga Satsuki, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, 2025年03月, 査読あり, 招待無し

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Nagayasu Atsushi, Miyazaki Yusuke, Sonomoto Koshiro, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Tanaka Hiroaki, Todoroki Yasuyuki, Ueno Masanobu, Aritomi Takafumi, Fujita Yuya, Sakai Hidenori, Suzuki Katsunori, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, 2025年08月, 査読あり, 招待無し

Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.
Ohkubo Naoaki, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Inoue Yoshino, Satoh-Kanda Yurie, Tanaka Hiroaki, Todoroki Yasuyuki, Miyata Hiroko, Nagayasu Atsushi, Funada Masashi, Kobayashi Hiroki, Sakai Hidenori, Kosaka Shumpei, Matsunaga Satsuki, Tomoyose Yukiko, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, 2024年10月, 査読あり, 招待無し